Batch two: ten more surging repos, and only five leave a real first-seller opening

Asked (summary)

Which GitHub repos are surging in popularity right now with potential to be commercialized and sold into enterprises — the asker wants to become their first seller.

Asked (follow-up)

“Give me 10 more.”

A second batch of ten repositories, distinct from the first report’s ten, researched as of 2026-09-10 — one row per repo with recent growth signal, reported stars where available, a semantic sales-fit score, license, and commercial-motion research. Momentum figures come from heterogeneous trend reports and are directional, not apples-to-apples. Five of the ten show no existing paid sales motion; five already have one underway.

The opportunity board: momentum vs commercial whitespace

green — clear first-seller opening yellow — opening, but early commercialization signals red — existing motion; pitch a job or partnership, not first sales bar length = semantic sales-fit score (0–100) · hover a bar for buyer, pilot and caveat

code-review-graph is the cleanest whitespace: +10,341 stars in a month to 29,657 total, an individual maintainer, and no paid offer found. techaimag.com

holaOS has the strongest sustained momentum — +3.3k stars in 7 days, seen on 8 recent days — but an enterprise tier and sales email already exist. findarepo.com

OpenBot scores the best sales fit in the batch (66.1) yet CopilotKit raised a $27M Series A to build its own enterprise layer. explainx.ai

Graft is MIT-licensed with no paid license found, but the fetched page names NanoNets/Graft while the URL stays trailhq/Graft — verify ownership first. opentools.ai

Buyer, first paid pilot and evidence, repo by repo

All ten rows

#	Repository	Recent growth	Stars	Fit	License	Motion	Sources

Second batch of ten repositories from a 2026-09-10 research pass; one row per repo with rank, growth signal, reported total stars, recent days seen, semantic sales-fit score (0–100), license and commercial-motion research. Momentum values come from mixed trend reports and are directional: one source counts views (OpenMed), Graft’s joined trend fields are blank, and Shockwave is a much smaller speculative candidate. Before outreach verify live star history, ownership, contributor health, license and trademark rights, maintainer willingness, existing sellers, and security claims — no one may lawfully represent or resell a project without an agreement. Long research notes trimmed for space.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.